Company Jerusalem Pharmaceutical Co. Palestine Exchange
Equities
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- | - |
|
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Medicines and Medical and Veterinary Medicines Supplies
99.5
%
| - | - | 39 | 99.5 % | - |
Prints
0.5
%
| 0 | 0.4 % | 0 | 0.5 % | +0.53% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Palestine
100.0
%
| 46 | 100.0 % | 40 | 100.0 % | -14.06% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 13-06-30 | |
Mohammed Natour
DFI | Director of Finance/CFO | - | 20-02-29 |
Chief Tech/Sci/R&D Officer | - | 88-12-31 | |
Director/Board Member | 58 | 08-12-31 | |
Omar Al Jabari
HRO | Human Resources Officer | - | - |
Corporate Officer/Principal | - | 94-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 89 | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Director/Board Member | 58 | 08-12-31 | |
Director/Board Member | 78 | - | |
Chief Tech/Sci/R&D Officer | - | 88-12-31 | |
Majid Al-Helo
BRD | Director/Board Member | - | - |
Saleem Yahia
BRD | Director/Board Member | - | - |
Director/Board Member | 67 | - | |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,000,000 | 6,479,988 ( 36.00 %) | 0 | 36.00 % |
Company contact information
![address Jerusalem Pharmaceutical Co.](https://cdn.zonebourse.com/static/address/20703773.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+20.39% | 43.67B | |
+27.72% | 22.79B | |
+21.43% | 15.45B | |
+18.82% | 14.29B | |
+53.37% | 12.83B | |
-0.05% | 6.79B | |
-12.18% | 6.52B | |
-8.87% | 5.73B | |
+15.72% | 5.59B |
- Stock Market
- Equities
- JPH Stock
- Stock
- Company Jerusalem Pharmaceutical Co.